Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jos Prickaerts

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
IUBMB Life|November 7, 2012
Phosphodiesterases in neurodegenerative disordersEva Bollen, Jos Prickaerts
EXS|October 6, 2006
Interactions between CRF and acetylcholine in the modulation of cognitive behaviourGeoff Warnock, Jos Prickaerts, Thomas Steckler
Behavioural Brain Research|May 2, 2006
Analysis of spatial orientation strategies of male and female Wistar rats in a Morris water escape taskArjan Blokland, Kris Rutten, Jos Prickaerts
Experimental Neurology|June 14, 2002
Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathwayRonald Deumens, Arjan Blokland, Jos Prickaerts
Learning & Memory (Cold Spring Harbor, N.Y.)|December 17, 2015
Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approachSven Akkerman, Arjan Blokland, Jos Prickaerts
Behavioural Brain Research|February 26, 2018
Acute stress negatively affects object recognition early memory consolidation and memory retrieval unrelated to state-dependencyEllis Nelissen, Jos Prickaerts, Arjan Blokland
Current Neuropharmacology|February 18, 2014
Purinergic signaling and hippocampal long-term potentiationRobert Düster, Jos Prickaerts, Arjan Blokland
Expert Opinion on Therapeutic Patents|April 6, 2012
PDE inhibition and cognition enhancementArjan Blokland, Frank S Menniti, Jos Prickaerts
Neurobiology of Learning and Memory|December 13, 2003
Learning and adult neurogenesis: survival with or without proliferation?Jos Prickaerts, Guido Koopmans, Arjan Blokland, et al.
Expert Opinion on Investigational Drugs|August 4, 2017
Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's diseaseJos Prickaerts, Pim R A Heckman, Arjan Blokland
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
IUBMB Life|November 7, 2012
Phosphodiesterases in neurodegenerative disordersEva Bollen, Jos Prickaerts
EXS|October 6, 2006
Interactions between CRF and acetylcholine in the modulation of cognitive behaviourGeoff Warnock, Jos Prickaerts, Thomas Steckler
Behavioural Brain Research|May 2, 2006
Analysis of spatial orientation strategies of male and female Wistar rats in a Morris water escape taskArjan Blokland, Kris Rutten, Jos Prickaerts
Experimental Neurology|June 14, 2002
Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathwayRonald Deumens, Arjan Blokland, Jos Prickaerts
Learning & Memory (Cold Spring Harbor, N.Y.)|December 17, 2015
Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approachSven Akkerman, Arjan Blokland, Jos Prickaerts
Behavioural Brain Research|February 26, 2018
Acute stress negatively affects object recognition early memory consolidation and memory retrieval unrelated to state-dependencyEllis Nelissen, Jos Prickaerts, Arjan Blokland
Current Neuropharmacology|February 18, 2014
Purinergic signaling and hippocampal long-term potentiationRobert Düster, Jos Prickaerts, Arjan Blokland
Expert Opinion on Therapeutic Patents|April 6, 2012
PDE inhibition and cognition enhancementArjan Blokland, Frank S Menniti, Jos Prickaerts
Neurobiology of Learning and Memory|December 13, 2003
Learning and adult neurogenesis: survival with or without proliferation?Jos Prickaerts, Guido Koopmans, Arjan Blokland, et al.
Expert Opinion on Investigational Drugs|August 4, 2017
Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's diseaseJos Prickaerts, Pim R A Heckman, Arjan Blokland
Pageof 17